Serotipos y susceptibilidad antimicrobiana de Streptococcus agalactiae

Background : Streptococcus agalactiae or group B streptococcus, GBS, is the leading cause of neonatal and maternal infections and an opportunistic pathogen in adults with underlying disease. In the last decade, a dramatic increase in the resistance of this microorganism to erythromycin and clindamycin has been observed. Aim: To determine the serotype distribution and antimicrobial susceptibility of isolates of S agalactiae collected from infections and colonization and to assess the genetic mechanisms of macrolide and clindamycin resistance. Material and methods: A total of 100 GBS isolates were collected between 1998 and 2002, in Santiago, Chile. They were isolated from the amniotic fluid from patients with premature rupture of membranes (7 isolates), blood from neonatal sepsis (10 isolates), neonate colonizations (2 strains), skin and soft tissue infections (7 isolates), urinary tract infections (5 isolates), genital infections (3 isolates), articular fluid (one isolate), and 65 strains were recovered from vaginal colonization55. Results: Serotypes Ia, II and III were the predominant serotypes identified in our study, accounting for 90 (90%) of the strains. Five isolates belonged to serotypes Ib (5%) and two (2%) to serotype V respectively; no strains belonging to serotype IV were found. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four isolates (4%) were resistant to both erythromycin (MIC >64 µg/ml) and clindamycin (MIC >64 µg/ml). The strains had a constitutive macrolide-lincosamide-streptogramin (cMLSB) resistance phenotype and the erm(A) gene was present in the four isolates. Conclusions: Serotypes Ia, II and III were the predominant serotypes in this study. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four (4%) strains were resistant to both erythromycin and clindamycin. The cMLSB resistance phenotype, and the erm(A) gene was detected in resistant strains (Rev Méd Chile 2004; 132: 549-55).

Saved in:
Bibliographic Details
Main Authors: Martínez T,María Angélica, Ovalle S,Alfredo, Durán T,Claudia, Reid S,Iván, Urriola J,Gabriela, Garay G,Beatriz, Cifuentes D,Marcela
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2004
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000500003
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872004000500003
record_format ojs
spelling oai:scielo:S0034-988720040005000032005-11-18Serotipos y susceptibilidad antimicrobiana de Streptococcus agalactiaeMartínez T,María AngélicaOvalle S,AlfredoDurán T,ClaudiaReid S,IvánUrriola J,GabrielaGaray G,BeatrizCifuentes D,Marcela Drug resistance, microbial Serotyping Streptococcus agalactiae Background : Streptococcus agalactiae or group B streptococcus, GBS, is the leading cause of neonatal and maternal infections and an opportunistic pathogen in adults with underlying disease. In the last decade, a dramatic increase in the resistance of this microorganism to erythromycin and clindamycin has been observed. Aim: To determine the serotype distribution and antimicrobial susceptibility of isolates of S agalactiae collected from infections and colonization and to assess the genetic mechanisms of macrolide and clindamycin resistance. Material and methods: A total of 100 GBS isolates were collected between 1998 and 2002, in Santiago, Chile. They were isolated from the amniotic fluid from patients with premature rupture of membranes (7 isolates), blood from neonatal sepsis (10 isolates), neonate colonizations (2 strains), skin and soft tissue infections (7 isolates), urinary tract infections (5 isolates), genital infections (3 isolates), articular fluid (one isolate), and 65 strains were recovered from vaginal colonization55. Results: Serotypes Ia, II and III were the predominant serotypes identified in our study, accounting for 90 (90%) of the strains. Five isolates belonged to serotypes Ib (5%) and two (2%) to serotype V respectively; no strains belonging to serotype IV were found. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four isolates (4%) were resistant to both erythromycin (MIC >64 µg/ml) and clindamycin (MIC >64 µg/ml). The strains had a constitutive macrolide-lincosamide-streptogramin (cMLSB) resistance phenotype and the erm(A) gene was present in the four isolates. Conclusions: Serotypes Ia, II and III were the predominant serotypes in this study. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four (4%) strains were resistant to both erythromycin and clindamycin. The cMLSB resistance phenotype, and the erm(A) gene was detected in resistant strains (Rev Méd Chile 2004; 132: 549-55).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.132 n.5 20042004-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000500003es10.4067/S0034-98872004000500003
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Martínez T,María Angélica
Ovalle S,Alfredo
Durán T,Claudia
Reid S,Iván
Urriola J,Gabriela
Garay G,Beatriz
Cifuentes D,Marcela
spellingShingle Martínez T,María Angélica
Ovalle S,Alfredo
Durán T,Claudia
Reid S,Iván
Urriola J,Gabriela
Garay G,Beatriz
Cifuentes D,Marcela
Serotipos y susceptibilidad antimicrobiana de Streptococcus agalactiae
author_facet Martínez T,María Angélica
Ovalle S,Alfredo
Durán T,Claudia
Reid S,Iván
Urriola J,Gabriela
Garay G,Beatriz
Cifuentes D,Marcela
author_sort Martínez T,María Angélica
title Serotipos y susceptibilidad antimicrobiana de Streptococcus agalactiae
title_short Serotipos y susceptibilidad antimicrobiana de Streptococcus agalactiae
title_full Serotipos y susceptibilidad antimicrobiana de Streptococcus agalactiae
title_fullStr Serotipos y susceptibilidad antimicrobiana de Streptococcus agalactiae
title_full_unstemmed Serotipos y susceptibilidad antimicrobiana de Streptococcus agalactiae
title_sort serotipos y susceptibilidad antimicrobiana de streptococcus agalactiae
description Background : Streptococcus agalactiae or group B streptococcus, GBS, is the leading cause of neonatal and maternal infections and an opportunistic pathogen in adults with underlying disease. In the last decade, a dramatic increase in the resistance of this microorganism to erythromycin and clindamycin has been observed. Aim: To determine the serotype distribution and antimicrobial susceptibility of isolates of S agalactiae collected from infections and colonization and to assess the genetic mechanisms of macrolide and clindamycin resistance. Material and methods: A total of 100 GBS isolates were collected between 1998 and 2002, in Santiago, Chile. They were isolated from the amniotic fluid from patients with premature rupture of membranes (7 isolates), blood from neonatal sepsis (10 isolates), neonate colonizations (2 strains), skin and soft tissue infections (7 isolates), urinary tract infections (5 isolates), genital infections (3 isolates), articular fluid (one isolate), and 65 strains were recovered from vaginal colonization55. Results: Serotypes Ia, II and III were the predominant serotypes identified in our study, accounting for 90 (90%) of the strains. Five isolates belonged to serotypes Ib (5%) and two (2%) to serotype V respectively; no strains belonging to serotype IV were found. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four isolates (4%) were resistant to both erythromycin (MIC >64 µg/ml) and clindamycin (MIC >64 µg/ml). The strains had a constitutive macrolide-lincosamide-streptogramin (cMLSB) resistance phenotype and the erm(A) gene was present in the four isolates. Conclusions: Serotypes Ia, II and III were the predominant serotypes in this study. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four (4%) strains were resistant to both erythromycin and clindamycin. The cMLSB resistance phenotype, and the erm(A) gene was detected in resistant strains (Rev Méd Chile 2004; 132: 549-55).
publisher Sociedad Médica de Santiago
publishDate 2004
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000500003
work_keys_str_mv AT martineztmariaangelica serotiposysusceptibilidadantimicrobianadestreptococcusagalactiae
AT ovallesalfredo serotiposysusceptibilidadantimicrobianadestreptococcusagalactiae
AT durantclaudia serotiposysusceptibilidadantimicrobianadestreptococcusagalactiae
AT reidsivan serotiposysusceptibilidadantimicrobianadestreptococcusagalactiae
AT urriolajgabriela serotiposysusceptibilidadantimicrobianadestreptococcusagalactiae
AT garaygbeatriz serotiposysusceptibilidadantimicrobianadestreptococcusagalactiae
AT cifuentesdmarcela serotiposysusceptibilidadantimicrobianadestreptococcusagalactiae
_version_ 1755988132394696704